World supplier of antibodies, antigens and kits since 2007
Other Products

Anti-TIM3 (cobolimab biosimilar) mAb

Human
ELISA, Flow Cyt
$255/ 50μg
Quantity
Total: $255

Ship worldwide. Contact order@enogene.com for ordering and bulk pricing or contact your local distributor.

Price255$

Product Information

NameTSR-022
SpeciesHumanized
IsotypeMonoclonal
FormulationLiquid
Recommended DilutionsELISA 1:5000-10000
Cite ID#EN5598072
Product TypeReference antibody

All Names

AlternameHAVCR2, TIM3, TIMD3, FLJ14428, KIM3
Antibody typeIgG4

Form Or Antibody

Form of AntibodyLyophilized from sterile PBS, pH 7.4. Normally 5 % - 15 % trehalose is added as protectants before lyophilization.
PurificationPurified from cell culture supernatant by affinity chromatography
Storage/StabilityStorage/Stability
Human TIM3, HEK293 cell line transfected with bind Anti-TIM3 irrelevant protein (B) and human ng/ml. TIM3(A) were surface stained with anti-TIM3 neutralizing antibody 1μ g/ml (cobolimab) followed by Alexa 488-conjugated anti-rabbit IgG
Human TIM3, HEK293 cell line transfected with bind Anti-TIM3 irrelevant protein (B) and human ng/ml. TIM3(A) were surface stained with anti-TIM3 neutralizing antibody 1μ g/ml (cobolimab) followed by Alexa 488-conjugated anti-rabbit IgG
ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human TIM3, HEK293 cell line transfected with mFc-His tagged protein (E33ME100030) can bind Anti-TIM3 irrelevant protein (B) and human Neutralizing antibody in a linear range of 0.24-7.81 ng/ml. TIM3(A) were surface stained with anti-TIM3 neutralizing antibody 1μ g/ml (cobolimab) followed by Alexa 488-conjugated anti-rabbit IgG secondary antibody.
ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human TIM3, HEK293 cell line transfected with mFc-His tagged protein (E33ME100030) can bind Anti-TIM3 irrelevant protein (B) and human Neutralizing antibody in a linear range of 0.24-7.81 ng/ml. TIM3(A) were surface stained with anti-TIM3 neutralizing antibody 1μ g/ml (cobolimab) followed by Alexa 488-conjugated anti-rabbit IgG secondary antibody.